After in vivo inoculation with abl/myc-and raf/myccontaining retroviruses, BALB/c mice predominantly develop late stage B cell tumors (plasmacytomas) and less frequently develop earlier B-lineage tumors while DBA/2 mice do not develop B-lineage tumors. We have investigated the in vitro tumorigenic potential of these viruses using cultured normal pre-B cell lymphocytes from both BALB/c and DBA/2 mice. Interestingly, both viruses infect cultured pre-B lymphocytes from both mouse strains. Following infection, IL-7 dependent pre-B cells become independent of normal in vitro growth requirements within 24 h and can rapidly form in vivo pre-B lymphomas in both mouse strains. Mechanisms mediating loss of IL-7 dependence are dierent depending on whether the raf or abl gene is present in myccontaining viruses. IL-7 JAK-STAT signaling is constitutively active in abl/myc induced pre-B cell tumors. In contrast, IL-7 JAK-STAT signaling is not constitutive in raf/myc induced pre-B cell tumors, demonstrating that subversion of this component of IL-7 signal transduction is not obligatory for pre-B cell transformation or loss of IL-7 dependence.
Introduction
Dierences in resistance or susceptibility to transformation of B lineage cells can be readily observed in inbred mouse strains using a variety of in vitro tumor induction methods. For example, BALB/c mice are susceptibile to plasmacytomagenesis while DBA/2 mice are not (Silva et al., 1991) . In BALB/c mice, plasma cell tumors can be induced by intraperitoneal injection of several in¯ammatory stimuli including mineral oils (Potter and Boyce, 1962) , plastics (Merwin and Algire, 1959) ; pristane (Anderson and Potter, 1969) , and silicone polymers (Potter et al., 1995) . BALB/c plasma cell tumors are characterized by high constitutive myc gene overexpression associated with translocation of one of the c-myc genes into one of the immunoglobulin gene loci (Potter et al., 1995) . BALB/c plasmacytomas can also be induced by recombinant retroviruses carrying myc plus other oncogenes including raf (J3V1), and abl (ABL/MYC) (Largaespada et al., 1992; Troppmair et al., 1989) . Retrovirally induced plasmacytomas avoid the need for dysregulation of c-myc caused by translocation because the viruses express myc at high levels. Also, the latency of tumor formation is reduced because of the presence of a second oncogene expressed at high levels.
Although the ABL-MYC and J3V1 viruses most frequently cause plasmacytomas in susceptible mice, both can give rise to pre-B lymphomas upon in vivo inoculation. In weanling BALB/c mice the ABL-MYC virus induced pre-B tumors in one third of the mice while two thirds developed plasmacytomas (Largaespada et al., 1992) . J3V1 virus induces pre-B tumors in BALB/c nude mice (Hilbert et al., 1995) . In contrast to BALB/c mice, the ABL-MYC and J3V1 murine retroviruses do not induce B-lineage tumors in DBA/ 2 mice (Hilbert et al., 1996) . Both viruses induce myeloid lineage tumors in both DBA/2 and BALB/c mice. An unanswered question is whether tumors arising from dierent stages of dierentiation or dierent lineages arise by dierent mechanisms.
The reasons for dierence in tumorigenic potential of the two viruses have not been completely elucidated; however, work aimed at identi®cation of the target cell for viral infection in BALB/c mice has suggested that ABL-MYC virus-infected BALB/c bone marrow pre-B cells can dierentiate to plasma cell tumors subsequent to infection and preceding full transformation (Weissinger et al., 1993) . It is not known if DBA/2 pre-B cells can be infected in vivo. These considerations prompted us to determine if these viruses can infect and transform in vitro early B-lineage cells from both BALB/c and DBA/2 mouse strains.
In order to avoid the heterogeneity of cells selected from bone-marrow, we utilized a technique for tissue culture of normal, clonal pre-B cells to investigate the in vitro tumorigenic potential of the ABL-MYC and J3V1 viruses. This tissue culture method allows longterm propagation of normal pre-B cells from a variety of mouse strains . Both IL-7 and stromal cells are required for pre-B cell growth. The cultured cells retain the phenotype of normal precursor B cells by a variety of criteria including cell surface markers and immunoglobulin gene rearrangement status. They dierentiate into surface immunoglobulin positive cells both in vivo and in vitro, undergo immunoglobulin heavy chain and light chain isotype switching, form germinal centers in vivo and are not transformed. In vitro dierentiation is triggered by removal of either IL-7 or the stromal cells: 80 ± 90% of the cells die by apoptosis and 10 ± 20% of the cells acquire surface immunoglobulin expression (Ghia et al., 1995; .
Using this technique, we established pre-B cell lines from DBA/2 and BALB/c mice in order to examine the tumorigenic potential of the ABL-MYC and J3V1 viruses.
Results
Establishment of pre-B cell clones from BALB/c and DBA/2 mice In order to generate cell lines for investigations of the tumorigenic potential of the ABL-MYC virus, we established normal pre-B cell clones from fetal livers of prototypical virus-resistant (DBA/2) and susceptible (BALB/c) mice. Forty-three BALB/c and 24 DBA/2 pre-B cell clones were derived from four BALB/c and two DBA/2 fetal livers following limiting dilution as described in Materials and methods. Thus, an average of 11 clones per BALB/c fetal liver and 12 per DBA/2 fetal liver were derived, indicating that the clonable precursor B cell population was roughly equivalent. This is in agreement with previous studies which demonstrated no more than threefold variation in clonable pre-B cell abundance in dierent mouse strains .
As expected, and consistent with previous observations these cells grow well in the presence of stromal cells and IL-7 but die rapidly in media only. This was true of both the DBA/2 and the BALB/c cell clones. As shown in Figure 1 , we used [ 3 H]-thymidine incorporation to quantitatively assess proliferation of normal pre-B cell clones in the presence or absence of IL-7. This assay formed the basis for subsequent determinations of altered growth requirements following viral infections.
Establishment of an in vitro transformation assay
One potential explanation for the dierence between BALB/c and DBA/2 susceptibility to ABL-MYC virus B-lineage transformation could be strain-speci®c dierences in targets for infection such as target cell frequency or ability to bind and take up virus. We therefore determined if pre-B cells from both strains were infectable and if transformation could be demonstrated in vitro.
Growth factor independence is a common consequence of viral transformation (Anderson et al., 1990; Dean et al., 1987; Laneuville et al., 1992; McCubrey et al., 1993; Rapp et al., 1985; Rose and Reddy, 1992) . This suggested that an eective, rapid assay for in vitro viral transformation of normal pre-B cells might be growth without stromal cells and IL-7. We therefore selected three clones from each donor mouse strain and incubated them with the ABL-MYC virus. Following viral exposure, cells were plated without stromal cells in the presence or absence of IL-7.
Surprisingly, infected cells of both BALB/c and DBA/2 origin grew equally well in the absence of stromal cells with or without IL-7 ( Figure 2 ). As expected, uninfected cells died in the absence of both stromal cells and IL-7. In the presence of IL-7, uninfected pre-B cells did not replicate.
These experiments demonstrated that pre-B cells from both strains can be infected with ABL-MYC virus and that an early consequence of this infection is the abrogation of both stromal cell and IL-7 requirements.
ABL-MYC proviral integration and expression
We used PCR to con®rm that IL-7, stromal cellindependent clones of both DBA/2 and BALB/c origin had incorporated and were expressing the recombinant virus (Figure 3) . The c-myc primers yield a 345 base pair product if the provirus is integrated in the high molecular weight DNA since the provirus contains cDNA-derived c-myc sequences. DNA from uninfected cells does not yield c-myc product since the primer sites in exons 2 and 3 are separated by over 2 kb in the genomic DNA. ABL-MYC provirus integration was also detected using a 5' gag-speci®c primer with a c-abl 3' primer which would produce a 505 bp PCR product originating from the integrated ABL-MYC virus but no product in the absence of proviral DNA. This band was observed in all cells exposed to the virus but not in the uninfected cells.
These results formally demonstrate that pre-B cells of both BALB/c and DBA/2 origin can be infected by the ABL-MYC virus and that integration of the provirus occurs in pre-B cells of both strains. This result suggests that B-lineage cells are not inherently resistant to infection by the virus but that the lack of B-lineage tumors in DBA/2 must be due to other mechanisms.
The V preB gene primers generated the expected 427 bp product in all samples, demonstrating that comparable amounts of DNA were used for all PCR reactions and the none of the DNA preparations were grossly inhibitory to the PCR reaction.
We next used RT ± PCR to determine if integrated viruses were expressing RNA. Virus-speci®c mRNA containing gag and c-abl sequences was detected in ABL ± MYC infected cells but not in the uninfected original clones (Figure 3 ). This mRNA yielded a 505 bp product that spanned the gag-abl junction and could only arise from the ABL ± MYC virus. Both infected and uninfected cells also expressed c-myc and c-abl RNAs (Figure 3) . Most likely the c-myc mRNA in the infected cells arises from the virus since endogenous c-myc is transcriptionally silenced when ABL-MYC virus is present (Largaespada et al., 1992) .
V preB speci®c RT ± PCR product of 341 bp was seen in all clones, con®rming that comparable amounts of RNA were used in all PCR reactions ( Figure 3 ). V preB mRNA expression is restricted to the pre-B cell stage of B cell dierentiation (Okabe et al., 1992) demonstrating that the infected cells had not undergone dierentiation to later B cell developmental stages.
Phenotypes of transformed pre-B cells
The morphology and growth rates of the virallyinfected, growth-factor-independent cells did not change appreciably following infection. However, based on previous studies (Weissinger et al., 1993) , we anticipated that dierentiation to more mature Blineage cells could accompany transformation of pre-B cells by the ABL-MYC virus. Using¯ow cytometry, we examined markers that would discriminate between the pre-B, B and plasma cell stages of B cell dierentiation ( Figure 4 ). CD22 staining on BALB/c but not DBA/2 pre-B cell lines results from allele speci®city of the reagent which does not recognize the DBA/2 CD22 isoform.
The phenotypes of uninfected BALB/c and DBA/2 pre-B cells were similar. Both the infected and uninfected pre-B cells were B220 positive, and sIgM negative, consistent with the classical pre-B cell phenotype (reviewed in ). Following infection, there were some changes in cell surface phenotype, a number of which appeared speci®c to the strain of origin. For example, normal uninfected BALB/c pre-B cells have a subpopulation of ThB positive cells. Upon infection, the cells became uniformly ThB negative. In contrast, both infected and uninfected DBA/2 cells retained ThB positive subpopulations. A similar phenomenon occurred with the BP-1 marker although the line AM-B2-2 did not become completely BP-1 negative. An interesting dierence between BALB/c and DBA/2 is the induction of MHC Class II expression by the ABL-MYC virus in 2/3 of the DBA/2 pre-B cell lines but not in BALB/c lines ( Figure 4b ). Although MHC class II expression is primarily a mature B-cell marker, myconcogene induced pre-B cell tumors often express MHC Class II (Bender and Kuehl, 1987) .
These combined observations indicate no appreciable dierentiation beyond the stage of pre-B cells had occurred following ABL-MYC virus infection. This was con®rmed due to the observation of V preB mRNA expression in infected cells (Figure 3b ).
The phenotypes described above were stable for several passages both in terms of presence or absence of markers and in proportions of cells stained when heterogeneous populations were seen with a given marker.
J3V1 virus transformation
We next examined whether the J3V1 virus could also mediate transformation of pre-B cells. Based on the observation that J3V1-induced BALB/c plasmacytomas were IL-6 dependent (Hilbert et al., 1996) , we anticipated that J3V1 induced pre-B cell tumors may The presence of integrated ABL ± MYC provirus was demonstrated by PCR using high molecular weight genomic DNA and primers designed to speci®cally detect only integrated provirus. The V preB primer served as a control for the intactness and equivalence of DNA preparations used in each PCR reaction. (b) RNA expression from the integrated provirus was detected by PCR on cDNAs derived from the indicated cells. The gag-abl primer pair can react only with virus-derived RNA. The V preB primers served as a control for equivalence and intactness of the RNA used for each sample and to con®rm that the cells were of pre-B cell origin remain IL-7 dependent. Therefore, following exposure of BALB/c and DBA/2 pre-B-cells to J3V1 virus, we cultured cells without stromal layers with or without IL-7. Surprisingly, stromal cell independent pre-B cells arose with or without IL-7 in both BALB/c and DBA/ 2 cell lines within 24 h after infection. We con®rmed that the J3V1 virus treated cells contained integrated provirus and expressed the viral raf and myc genes by DNA and RT ± PCR ( Figure 5) .
As with ABL-MYC virus, J3V1 virus infection transformed pre-B cells but did not induce differentiation by two criteria. First, V preB gene expression did not cease after viral transformation ( Figure 5 ). Second, ow cytometry analysis of cell surface markers demonstrated that the infected and uninfected pre-B cells did not change appreciably with regard to markers that would indicate a change in developmental stage from pre-B to B or plasma cell tumor (not shown).
Subversion of IL-7 signal transduction
Earlier ®ndings suggested that constitutive activation of the JAK-STAT pathway by v-abl contributed to pre-B cell tumorigenesis through abrogation of IL-7 requirements (Danial et al., 1995) . Our observation that IL-7-independent cell lines could be obtained with both ABL-MYC and J3V1 viruses suggested that the IL-7 signal transduction pathway might be subverted by both. To investigate this question, we examined the status of the JAK-STAT signaling pathway activated by IL-7 treatment of normal and transformed pre-B cell counterparts. As expected, gel shift ( Figure 6a ) and supershift experiments with anti-STAT5 antibodies (not shown) demonstrated IL-7 induced STAT5 activation in normal pre-B cells. The ABL-MYC virus led to constitutive activation of STAT5 proteins in both BALB/c and DBA/2 pre-B cell tumors (Figure 6a ). This ®nding is consistent with the report of constitutive activation of this pathway in AMuLV transformed pre-B cells (Danial et al., 1995) . Interestingly, adding IL-7 to culture media of IL-7 independent, ABL ± MYC transformed lines led to additional STAT phosphorylation, suggesting that IL-7 receptor mediated signaling can enhance a basal level of constitutive activation induced by v-abl tyrosine kinase.
In similar fashion, we examined this pathway in J3V1 transformed cell lines (Figure 6b) . In contrast to the ABL ± MYC pre-B transformants, the J3V1 transformed IL-7 independent pre-B cell lines did not constitutively activate STAT proteins. However, this pathway remains inducible upon stimulation by IL-7, suggesting that the components of the pathway are functional but constitutive activation is not necessary for transformation to IL-7 independent growth.
Tumorigenic potential of normal, ABL-MYC, and J3V1 infected pre-B cell lines ABL-MYC and J3V1 infection of normal pre-B cell clones of both BALB/c and DBA/2 origin resulted in growth factor independent cells with stable pre-B cell phenotypes. The virally induced transition from stromal cell and IL-7 dependence to independence from growth factors suggested that the cells were fully transformed. In order to test this hypothesis and to assess the degree of transformation, we examined the tumorigenic potential of both the uninfected and infected pre-B cells in immunode®cient scid mice. None of the scid mice which received normal, uninfected pre-B cells at a dose of 1.5610 7 cells/ mouse developed any tumors during an observation period of 6 months. In contrast all scid recipients injected with 0.4610 7 ABL/MYC infected pre-B cell lines succumbed to pre-B tumors within 10 ± 18 days ( Table 1) . Tumorigenicity of J3V1 infected cells in scid mice was not assessed.
Because the scid host is immunode®cient, this experiment did not address the possibility that the dierence in in vivo viral resistance between DBA/2 and BALB/c could relate to dierences in ability to mount vigorous anti-tumor immunity. Therefore, we also examined tumorigenic potential of these cells in syngeneic immunocompetent recipients. Ascites tumors arose in both mouse strains with the same latency as was observed in the scid recipients (Table 1) .
The cell surface marker phenotypes of the ascites tumors were the same as the cell population used to inject the mice (not shown). This suggested that the peritoneal microenvironment had no ability to induce dierentiation of these cells. However, we tested the eect of pristane conditioning of the peritoneal cavity prior to injection of the infected pre-B cells to determine if this might allow dierentiation of pre-B tumors into more mature stages of B cell development. The use of pristane had no eect on the latency of the tumors of either DBA/2 or BALB/c origin. In addition, the phenotypes of infected pre-B cells injected into pristane conditioned hosts did not change. Another hallmark of dierentiation to the plasma cell stage of B cell development is secretion of immunoglobulin. Therefore, we tested infected cells for immunoglobulin secretion but found no IgM, IgA, or IgG production by these cells.
Discussion
In this report, the in vitro tumorigenic potential of abl/ myc and raf/myc containing retroviruses has been compared using normal precursor B cells originating from two mouse strains which exhibit opposite patterns of in vivo susceptibility to B cell tumorigenesis.
One potential mechanism of resistance to B-lineage tumor induction in the DBA/2 mouse could be simply an inability of the ABL ± MYC or J3V1 virus to infect DBA/2 B-lineage cells. However, normal DBA/2 pre-B cells were easily infectable and transformable by both viruses in vitro. This suggests that the strain-speci®c dierence in susceptibility to in vivo B-lineage tumorigenesis is not due to dierences in viral receptor expression or ability to undergo transformation following infection. This novel observation of DBA/2 B-lineage tumor induction also suggests that DBA/2 pre-B cells could potentially be infected in vivo even though B-lineage tumors are not observed following direct in vivo administration of these viruses. Another possible mechanism to explain strain-speci®c dierences could be that dissemination of these viruses is restricted in DBA/2 mice but not in BALB/c mice. However, this is unlikely since DBA/2 mice develop myeloid lineage tumors induced by raf/myc virus (Hilbert et al., 1996) . Large, strain-speci®c dierences in abundance of infectable early B-lineage target cells might also explain the susceptibility dierence. However, we and others did not ®nd signi®cant dierences in the frequency of clonable pre-B cells in BALB/c and DBA/2 mice. These considerations suggest strain-related dierences that either in¯uence pre-B cell infection in vivo, or in¯uence rejection of infected B-lineage cells.
Previous work has shown that Abelson murine leukemia virus (AMuLV), which has the same envelope as ABL ± MYC and J3V1, primarily transforms immature B lineage cells both in vivo and in vitro (reviewed in Rosenberg, 1982) . In contrast, a more recent report showed that in vitro ABL ± MYC virus infection of antibody-selected immature B cells from BALB/c fetal liver resulted in plasmacytomas (Weissinger et al., 1993) , suggesting that the combination of v-abl and myc gene overexpression allows differentiation of immature B cells to the plasma cell stage before full malignant transformation occurs. Our experiments began with clonal pre-B cells representing a narrow stage of B-lymphoid development which nonetheless retain the ability to dierentiate to mature B cells both in vitro and in vivo (reviewed in . Infection of these clonal pre-B cells, as opposed to puri®ed bone marrow cells, resulted exclusively in pre-B lymphomas with no evidence of dierentiation subsequent to infection. In addition, the in vivo peritoneal environment had no ability to induce dierentiation of the infected, growth factor independent pre-B cell lines. The contrast between these results suggests at least two possibilities: that interactions with the in vivo cellular environment exposes infected but as yet untransformed precursor B cells to dierentiation signals that are not present in the in vitro system we have used or that the immature B cell cultures described by Weissinger et al. (1993) could support target cells with a potential to dierentiate following ABL-MYC virus infection while this target cell type is not supported by our tissue culture method.
In vitro, AMuLV transformed cells can have low oncogenic potential that increases after 3 months of tissue culture (Whitlock and Witte, 1981) . In contrast, early passage abl/myc and raf/myc infected pre-B cell lines inoculated into mice were extremely tumorigenic with latency no greater than 18 days in both immunocompetent and immunode®cient recipients (Table 1) . Thus the combination of myc with either of two protein kinase oncogenes resulted in rapid in vitro pre-B cell transformation. This suggests that the transformation to in vivo tumorigenic capacity occurs with or shortly after transformation to in vitro growth factor independence.
Many observations suggest that loss of growth factor independence results from subversion of cytokine signal transduction through activation of various JAK-STAT pathways and that this plays a key role in malignant evolution of tumors. For example, the transition from IL-2-dependent to IL-2-independent growth of HTLV-I-transformed T cells correlates with the acquisition of a constitutively activated JAK-STAT pathway (Migone et al., 1995) .
In B cell tumorigenesis, the abl/myc virus constitutively activates the IL-6 JAK-STAT pathway in BALB/c plasmacytomas, suggesting a mechanism for development of IL-6 independent tumors (Hilbert et al., 1996) . Plasmacytomas induced by raf/myc remained IL-6 dependent and did not exhibit constitutive IL-6 JAK-STAT signaling (Hilbert et al., 1996) . Interestingly, our observations dier with respect to continued requirement for growth factor following raf/ myc mediated B cell tumorigenesis. Pre-B cells infected with the raf/myc virus rapidly lost IL-7 dependence despite the fact that the IL-7 JAK-STAT pathway was not constitutively activated. This observation suggests that the mechanism by which raf/myc mediates tumorigenesis may be dierent in dierent stages of B cell development. In contrast, the abl/myc virus led to constitutive activation of IL-7 JAK-STAT signal transduction pathway. This is consistent with previous observations that IL-7 signaling through the JAK- The presence of integrated J3V1 provirus was demonstrated by PCR using high molecular weight genomic DNA and primers designed to speci®cally detect only integrated provirus. The V preB primer served as a control for the intactness and equivalence of DNA preparations used in each PCR reaction. (b) RNA expression from the integrated provirus was detected by PCR using viral RNA-speci®c primers on cDNAs derived from the indicated cells. The V preB primers served as a control for equivalence and intactness of the RNA used for each sample and to con®rm that the cells were of pre-B cell origin Figure 6 IL-7 JAK-STAT signal transduction pathway in normal and virally transformed pre-B cells. (a) EMSA using lysates from ABL/MYC infected pre-B cell lines from BALB/c (designated B) or DBA/2 (designated D) grown with IL-7 (+) or without IL-7 (7) are compared to EMSA using lysates from an uninfected DBA/2 clone (D1-3) grown in the presence of IL-7, starved for 6 h, or pulsed for 20 min after IL-7 starvation. (b) EMSA using lysates from ABL/MYC (designated AM) or J3V1 (designated J3) infected counterpart lines that were grown with IL-7 (+) or without IL-7 (7). 128.3 is an ABL-MYC induced BALB/c plasmacytoma cell line previously shown to constitutively cause a STAT-speci®c shift with the FcgRI-GAS probe (Hilbert et al., 1996) STAT pathway can be constitutively activated by the vabl tyrosine kinase in AMuLV-induced pre-B lymphomas (Danial et al., 1995) . We have extended these observations by demonstrating that abl/myc infected pre-B cells from both DBA/2 and BALB/c exhibit constitutive IL-7 JAK-STAT activation. The constitutive activation of STAT5b by abl/myc virus in both BALB/c and DBA/2 pre-B tumors demonstrates that the v-abl tyrosine kinase can utilize both DBA/2 and BALB/c STAT5 substrates. Thus, allelic dierences in the components of at least part of the IL-7 signal transduction pathway can not explain DBA/2 resistance to in vivo tumorigenesis by the ABL ± MYC virus. Our observations suggest that examination of only one portion of a cytokine signal transduction pathway, speci®cally the JAK-STAT portion, may be misleading regarding cause and eect for cellular growth dysregulation. Engagement of IL-7 receptor (IL-7R) leads to activation of at least three signal transduction pathways involving intracellular tyrosine kinases of both the JAK and src families as well as phosphatidylinositol 3-kinase (PI-3 kinase) (Corcoran et al., 1996; Johnston et al., 1995) . Our results demonstrate that constitutive activation of the JAK-STAT pathway is not required for transformation of pre-B cells to IL-7 independence.
These results have several implications with regard to design of therapeutic approaches to human pre-B cell tumors. In humans, cancers aecting the B cell lineage are among the most common and pre-B acute lymphocytic leukemia is the most common malignancy in children (Lin and Li, 1996; Poplack et al., 1989; Smith, 1996; Wiernik et al., 1996) . If only the abl/myc tumors were considered, the approach of blocking IL-7 JAK-STAT activity by drug, biological, or gene therapy could appear to be an ecacious method for treatment of pre-B lymphoma. This rationale would be supported by several studies of the importance of cytokine signal subversion in lymphoid tumorigenesis (Danial et al., 1995; Hilbert et al., 1996; Migone et al., 1995) . However, we have shown that constitutive activation of the JAK-STAT component of the IL-7 signal transduction pathway is not required for pre-B lymphomagenesis.
Materials and methods

Mice
BALB/cAnNCR, DBA/2N, and C.B-17ICR SCID/SCID mice were obtained from the NIH animal facility at Frederick Cancer Research Animal Production Facility, (Frederick, MD).
Nucleic acid extraction
DNA was extracted essentially as described (Sambrook et al., 1989) . In order to isolate high molecular weight DNA, the DNA was wound out on a glass rod.
Total RNA was isolated from cells as published (Chomczynski and Sacchi 1987) .
PCR analysis of DNA
PCR analysis utilized 200 ng of genomic DNA in reaction mixtures containing 100 mM nucleotide triphosphates, 0.25 mM oligonucleotide primers, 0.04 U/ml Taq polymerase, and 16PCR buer (Perkin-Elmer Cetus, Foster City, CA). Thirty PCR cycles for the c-abl, V preB , and c-myc primers (0.25 mM) were done as follows: denaturation at 948C for 30 s, annealing at 558C for 30 s, and extension at 728C, 30 s. Conditions were the same for the 5'-gag ± 3'-abl primer pair except that the concentration was 1 mM and the annealing temperature was 588C. PCR products were analysed by electrophoresis through 2% agarose gels in TAE buer (Sambrook et al., 1989) . Sizes of the PCR products were detemined by comparison to a 123 bp ladder or molecular size standards (Gibco-BRL, Bethesda, MD). Following electrophoresis, PCR products were detected using either 0.5 mg/ml ethidium bromide or SYBER Green II (Molecular Probes) and scanning with a FluorImager (Molecular Dynamics) and image analysis software (ImageQuant, Molecular Dynamics).
RT ± PCR analysis cDNAs were made from 1 mg total RNA essentially as described (Scheuermann and Bauer, 1993) . Following synthesis, the cDNA was diluted to a total volume of 100 ml. PCR analysis utilized 1 ml of cDNA with PCR conditions as described above except that 34 cycles were done and the 5'-gag-3'abl primer pair were used at 0.25 mM. Detection of product, and image analysis were done as described above.
The PCR primer sequences were as follows: 5' c-myc
The PCR primers for c-myc, c-abl and V preB were derived from separate exons. Therefore, the c-myc and c-abl PCR products shown in Figure 3a and b could originate only from integrated provirus or from spliced RNAs. The V preB primers were from exons separated by only 86 bp (Kudo and Melchers, 1987 ) so product could form from either genomic DNA or from spliced RNA but would be distinguishable by size: 427 bp from genomic and 341 bp from RNA.
Derivation of normal pre-B cell clones
Pre-B cell cultures were initiated using fetal livers from days 13 ± 15 of embryonic development in BALB/c or DBA/2 mice. Livers were sterilely resected, a single cell suspension was made in PBS, and nucleated cells were counted. Cells were then centrifuged for 10 min at 1000 g. The cell pellet was resuspended in Iscove's media (Gibco/ BRL) containg 2% fetal calf serum (FCS), 5610
75 M 2-mercaptoethanol, penicillin/streptomycin, and 10% of a conditioned media containing 2000 U/ml of mouse IL-7. Serial dilutions containing from 20 to 6000 cells in 100 ml were plated into wells of a 96-well culture dish containing 1000 irradiated, adherent S10 stromal cells. Cells were incubated for 5 ± 7 days at 378C until colonies of round, lymphoid cells appeared. Tissue culture plates containing colonies in fewer than 34% of wells were examined for wells containing single colonies. These single colonies were then propagated to establish clones from each strain. Clones were established from three separate BALB/c fetal livers and two separate DBA/2 fetal livers. The clones were designated B to indicate BALB/c origin or D to indicate DBA/2 origin. The digits following these letters indicate the source and clone numbers.
Recombinant mouse IL-7 was obtained from culture supernatant of mouse 3T3 cells transfected with plasmid pBCMGS-neo-IL-7 (Gift of Fritz Melchers, Basel Institute for Immunology). This cell line was allowed to secrete into Iscoves media, 10% FCS for 2 weeks. A cell free supernatant was harvested by centrifugation and IL-7 was quanti®ed using ELISA with puri®ed recombinant mouse IL-7 as standard (IMMUNEX, CA).
Proliferation assays
10
4 pre-B cells were added to wells of a 96-well culture dish containing media with IL-7 as described above or with 4% FCS and no IL-7. Cultures were pulse labeled for 4 h by the addition of 0.5 mCi 3 H-thymidine at appropriate times. Triplicate wells were harvested and counted at 4, 8, 24, 48 and 72 h after initiation of culture.
Cell surface marker analysis
The cell-surface phenotype of normal and tumor cells was determined by¯ow cytometry essentially as described (Hilbert et al., 1993) . Aliquots of 10 6 cells were incubated for 30 min at 48C with an FcR blocking antibody 2.4G2 (Pharmingen, San Diego, CA) and the following directly labeled antibodies: anti-BP-1-FITC, anti-CD22-PE, anti-MHC class II-FITC, anti-IgM-FITC (Pharmingen, San Diego, CA) anti-CD11b-PE (Mac-1), anti-CD5-FITC (Boehringer Mannheim, Indianapolis, IN), anti-CD45R(B220)-PE (Gibco/BRL), anti-ThB-FITC(Sigma), were then added. After an additional 30 min incubation on ice, cells were washed twice, then resuspended in PBS, 2% FCS. Cell surface¯uorescence was analysed on a Becton Dickinson FACSCAN. Non-viable cells were excluded by uptake of propidium iodide. B220 (CD45R) is expressed on all B lineage cells. BP-1 is a pre-B cell marker. ThB appears on pre-B and early B cells. IgM is a mature B cell marker. CD22 is an allele speci®c marker of BALB/c B lineage cells from pre-B to mature B cell stages. Mac-1 is a myeloid lineage marker. MHC class II is a marker of normal B cells and some transformed pre-B cells.
Gel shift assays
Whole cell extracts were prepared as follows: 1 ± 3610 7 cells were harvested and rapidly cooled with ice-cold phophate buered saline and centrifuged at 48C. Pelleted cells were snap-frozen in liquid nitrogen and stored at 7808C. Frozen pellets were resuspended in 1 ml of ice cold PBS, transferred to an eppendorf tube and centrifuged at +48C at 2500 r.p.m. Washed cells were rapidly resuspended in ice-cold lysis buer containing 20 mM HEPES pH 7.9, 100 mM KCl, 1 mM MgCl 2 , 10% glycerol, 0.1% NP-40, 0.5 mM sodium orthovanadate, 1 mM AEBSF [4-(2 aminoethyl-benzenesulfonyl-¯uoride)], and 5 mM NaF. Cells were incubated on ice for 15 min and lysates cleared by centrifuging at 14 000 r.p.m. at +48C. Protein content was determined (Bio-Rad Protein Assay; BioRad, CA) and supernatants were transferred to a new microfuge tube and stored at 7808C.
Electrophoretic mobility shift assays (EMSA) were done as follows: 5 ± 10 mg (10 ± 20 ml) of whole cell extract was added to 30 ml of binding cocktail containing 16.7 mM Tris, pH 7.4, 8.3 mM MgCl 2 167 mM KCl, 1.7 mM DTT, 17% glycerol. One ng of 32 P-labeled probe was added and the binding reaction incubated on ice for 15 min. 2 ml of loading dye was added and the mixture electrophoresed on a 6% acrylamide gel in 0.256TBE. Gels were run at 285 volts for approximately 2 h and dried on 3 mm Whatmann paper and exposed overnight to Molecular Dynamics Phosphorimager screens. The probe used for EMSA was a double-stranded oligonucleotide derived from the FcgRI GAS which contains the STAT binding motif (5' AGCTTGTATTTCCCA-GAAAAGGGATC). 300 ng of annealed oligo was endlabeled in a 50 ml reaction with polynucleotide kinase and 50 mCi of a 32 P-dGTP. The labeled oligo was puri®ed on a Bio-Spin 6 chromatography column (Bio-Rad).
To con®rm the identity of the STAT complex induced by IL-7, supershift assays were done as above with the addition of STAT5b speci®c monoclonal antibody (SantCruz Biotechnology, SantaCruz, CA) to the binding reaction according to the manufacturer's recommendation. An additional retardation is caused by the antibody when STAT5b is a component of the probe-STAT complex.
